Pfizer announced the major investigation yesterday, writing American media. There is currently no vaccine against Lyme disease on the market. Twenty years ago there was in the United States, but that vaccine had so many side effects that it was withdrawn from the market.
According to Pfizer, which made the vaccine together with France’s Valneva, it involves a drug that must be received three times.
According to NBC News, the pharmaceutical company is looking for thousands of test subjects who want to try the drug. If all goes well, Pfizer hopes to file an application for approval of the vaccine with the US Food and Drug Administration (FDA) by 2025.
In the Netherlands, Amsterdam UMC is involved in the study. Online writes have had one or more tick bites annually in the past and expect this to happen again in the coming year’. Interested subjects are due next month.
After tick bite
You can contract Lyme disease after a tick bite. The risk analysis is greatest in Drenthe, the National Institute for Public Health and the Environment (RIVM) concluded earlier this year.
Less than 1 in 5 signs carries Lyme disease, a disease that can manifest itself in, among other things, joint, skin, nerve or heart complaints.
About 27,000 people get Lyme disease every year. In most cases, Lyme disappears after treatment with antibiotics, they recover completely, but a part still struggles with the complaints for a long time.